Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF + chemotherapy in advanced NSCLC
NCT00994097Phase 2Completed
- Sponsor
- AGC Biologics
- Start
- Jul 2009
- Primary completion
- Mar 2017
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of NGR-TNF in non-small cell lung cancer (NSCLC), sponsored by AGC Biologics. Started Jul 2009; status: completed.
02
Drugs
NGR-TNF
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00994097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994097.